Skip to main content
. 2019 Jan 4;10(2):203–208. doi: 10.1021/acsmedchemlett.8b00551

Scheme 2. Synthetic Route B to Novel RXR Agonists.

Scheme 2

Ragents and conditions: (a) EDC·HCl, 4-DMAP, CHCl3, reflux, 63%; (b) oxone, DMF, rt, 29%; (c) NaBH(OAc)3, DCE, HOAc, rt, 91%; (d) glacial acetic acid, formaldehyde, reflux, 54%.